Updating the database of the Illinois Compiled Statutes (ILCS) is an ongoing process.
Recent laws may not yet be included in the ILCS database, but they are found on this site as
Public
Acts soon after they become law. For information concerning the relationship between statutes and Public Acts, refer to the
Guide.
Because the statute database is maintained primarily for legislative drafting purposes,
statutory changes are sometimes included in the statute database before they take effect.
If the source note at the end of a Section of the statutes includes a Public Act that has
not yet taken effect, the version of the law that is currently in effect may have already
been removed from the database and you should refer to that Public Act to see the changes
made to the current law.
(410 ILCS 416/20)
Sec. 20. Requirements; notice. (a) The program: (1) must collaborate with physicians, health care |
| providers, and clinical trial sponsors to notify a prospective subject about the program when:
|
|
(A) the prospective subject consents to a
|
|
(B) funding is available to provide the program
|
| for the clinical trial in which the prospective subject participates;
|
|
(2) must reimburse subjects based on financial need,
|
| which may include reimbursement to subjects whose income is at or below 700% of the federal poverty level;
|
|
(3) must provide reimbursement for ancillary costs,
|
| including costs described under Section 15, to eliminate the financial barriers to enrollment in a clinical trial;
|
|
(4) may provide reimbursement for reasonable
|
| ancillary costs, including costs described under Section 15, to one family member, friend, or other person who attends a clinical trial to support a subject; and
|
|
(5) must comply with applicable federal and State
|
|
(b) The independent third-party organization administering the program shall provide written notice to prospective subjects of the requirements described under subsection (a).
(Source: P.A. 103-227, eff. 6-30-23.)
|